Large Phase III Trial Seeks Optimal Use Of Tykerb vs. Herceptin In Breast Cancer
Most Older Men With Early Prostate Cancer Can Avoid Treatment, Analysis Finds
Extent Of Risk Reduction From Ovary Removal Varies According To BRCA Mutation
Smoking Increases Breast Cancer Risk Based on Genes
Larynx Preservation Provides Better Voice Quality For Patients
PET Better At Evaluating Response In Sarcoma
Sorafenib Targets AML Driven By Mutant FLT3 Gene
NCI Cooperative Group, Cancer Center Trials Listed
Trending Stories
- Knight Cancer Institute receives record-setting $2B gift from the Knights—and self-governance within OHSU
Brian Druker returns to executive role as president of the new Knight Cancer Group - Banished from the institute he founded, separated from his lab materials, Tom Curran sues Children’s Mercy
Whistleblower lawsuit alleges wrongful firing - ACOG says it will no longer accept federal funding
- Lou Weiner: Poetry and art help us imagine my mother’s world as a hidden child of the Holocaust
- When public service ends abruptly, do books provide solace? An escape? Perspective?
Former NIH and FDA employees tell us what they are reading in 2025 - Duke Officials Silenced Med Student Who Reported Trouble in Anil Potti’s Lab